Cullen Frost Bankers Inc. Has $2.56 Million Stake in Colgate-Palmolive (NYSE:CL)

Cullen Frost Bankers Inc. increased its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,074 shares of the company’s stock after buying an additional 436 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Colgate-Palmolive were worth $2,557,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Morgan Stanley lifted its position in shares of Colgate-Palmolive by 3.2% during the 3rd quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock valued at $1,195,785,000 after acquiring an additional 514,559 shares during the period. Northern Trust Corp raised its stake in Colgate-Palmolive by 3.3% in the third quarter. Northern Trust Corp now owns 9,452,931 shares of the company’s stock valued at $672,198,000 after purchasing an additional 305,862 shares in the last quarter. American Century Companies Inc. raised its stake in Colgate-Palmolive by 2.0% in the third quarter. American Century Companies Inc. now owns 6,590,405 shares of the company’s stock valued at $468,644,000 after purchasing an additional 127,805 shares in the last quarter. FMR LLC lifted its position in Colgate-Palmolive by 27.3% during the third quarter. FMR LLC now owns 5,597,742 shares of the company’s stock worth $398,055,000 after purchasing an additional 1,199,660 shares during the period. Finally, Nordea Investment Management AB grew its stake in Colgate-Palmolive by 10.1% during the third quarter. Nordea Investment Management AB now owns 5,455,384 shares of the company’s stock worth $390,005,000 after buying an additional 500,916 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.4 %

Shares of NYSE CL opened at $93.83 on Thursday. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $94.40. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70. The firm has a market cap of $76.98 billion, a PE ratio of 29.58, a price-to-earnings-growth ratio of 3.43 and a beta of 0.40. The company has a 50 day simple moving average of $88.64 and a 200 day simple moving average of $82.63.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.73 earnings per share. On average, research analysts forecast that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.13%. Colgate-Palmolive’s payout ratio is presently 63.29%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. The Goldman Sachs Group initiated coverage on shares of Colgate-Palmolive in a report on Friday, March 1st. They set a “buy” rating and a $93.00 price target for the company. Barclays upped their target price on Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 30th. Wells Fargo & Company lifted their price target on Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a research note on Monday, April 29th. Evercore ISI boosted their price target on Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a report on Monday, April 8th. Finally, Citigroup raised their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, April 16th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $91.44.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, CEO Noel R. Wallace sold 29,772 shares of the company’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $84.06, for a total transaction of $2,502,634.32. Following the sale, the chief executive officer now owns 301,343 shares in the company, valued at approximately $25,330,892.58. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. In the last quarter, insiders have sold 159,048 shares of company stock worth $13,336,846. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.